FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

Not Applicable

Completed

• Conditions: Lung Cancer, Nonsmall Cell; Small Cell Lung Cancer
• Interventions: Device: FLT-PET

• Registration Number: NCT02995889
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in patients with irradiated lung cancer in comparison with FDG-PET/CT.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11
• Study First Submitted: 2016-12-09
• Study First Submitted QC: 2016-12-16
• Study First Posted: 2016-12-19
• Primary Completion: 2019-02-07
• Study Completion: 2020-02-07
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-03
• Last Update Posted: 2022-05-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• history with lung cancer, small cell or non-small cell
• radiotherapy of lung cancer ended within the last 24 months
• radiotherapy might be normofractionated or stereotactic
• current suspicion of relapse
• written and oral consent

Exclusion Criteria

• communication difficulties
• pregnancy or lactation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
FLT-PET	FLT-PET	-

Primary Outcome Measures

Name	Time	Method
Number of patients with local and/or regional relapse	6 months

Trial Locations

Locations (2)

Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet; 🇩🇰 Copenhagen, Denmark

Dept. Respiratory Medicine, Bispebjerg University Hospital; 🇩🇰 Copenhagen, Denmark